María‐Eugenia Zaballa

Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study

Antonio Leidi, Flora Koegler, Roxane Dumont et al. · Clinical Infectious Diseases · 2021 · 73 citations · Full text

Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021

Silvia Stringhini, María‐Eugenia Zaballa, Nick Pullen et al. · Eurosurveillance · 2021 · 70 citations · Full text

Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study

María‐Eugenia Zaballa, Javier Perez‐Saez, Carlos de Mestral et al. · The Lancet Regional Health - Europe · 2022 · 59 citations · Full text

Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance

Javier Perez‐Saez, María‐Eugenia Zaballa, Sabine Yerly et al. · Clinical Microbiology and Infection · 2021 · 51 citations · Full text

Vaccination, Anti-sars-cov-2 Antibodies, Viral Persistence +6

Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study

Antonio Leidi, Flora Koegler, Roxane Dumont et al. · 2021 · 29 citations · Full text

Immunodeficiencies, Covid-19 Epidemiology, Covid-19 +16